Le congrès de la société française d’angiogenèse aura lieu du 4 au 6 juin avec des invités de très haut niveau ! Les inscriptions sont ouvertes et les abstracts peuvent être envoyés jusqu’au 11 avril. @sf_angiogenese https://t.co/OocNDoi1uE
Speakers, poster presenters, moderators, chair, debate moderators…the @BaillyLab was very much involved in HHT meeting 2025 @curehht. Very proud of our 2 PhD students Lea Vialet and Yasmin Rida for winning a travel award and Lea Vialet for the best presentation award.
This is our last newborn! BMP9 is a key player in endothelial identity and its loss is sufficient to induce arteriovenous malformations https://t.co/W5TkESmE99
We are thrilled to share our latest work on the characterization of an homozygous BMP9 mutations leading to HHT and PAH symptoms. https://t.co/ELIB8W8pw6
@RuiBenedito_@HellmutAugustin@RuhrbergLab@ralfhadams Yes. We compared tamoxifen only, creERT2 only, and tamoxifen + CreERT2 (It is in the data supplement S1). The problem is really the tamoxifen activated CreERT2... It can be complicated to add this tamox+Cre control but it seems necessary
https://t.co/49bJwfWSCu
We are happy to announce the publication of our latest paper about Cre toxicity in mouse models. Good to know for all groups working with Cre-lox system !
https://t.co/49bJwfWSCu
Post-doctoral position in microRNA bioinformatics aiming at the prediction of microRNA expression at the single cell level, the validation, and the use of these predictions to better understand microRNA modes of action in cancer.
https://t.co/RX6b3pAFPp
Please share.